| Anti-vascular endothelial growth factor therapy and retinal non-perfusion in diabetic retinopathy: a meta-analysis of randomised trials. | 2024 | Acta Ophthalmologica |
| Efficacy and safety of brolucizumab, aflibercept, and ranibizumab for the treatment of patients with visual impairment due to diabetic macular oedema: a systematic review and network meta-analysis. | 2023 | Diabetes Therapy |
| Efficacy and safety of anti-vascular endothelial growth agents for the treatment of polypoidal choroidal vasculopathy: a systematic review and meta-analysis. | 2023 | Survey of Ophthalmology |
| Comparative efficacy of aflibercept and ranibizumab in the treatment of age-related macular degeneration with retinal pigment epithelial detachment: a systematic review and network meta-analysis. | 2023 | BMC Ophthalmology |
| Baseline diabetic retinopathy severity and time to diabetic macular edema resolution with ranibizumab treatment: a meta-analysis. | 2023 | Ophthalmology Retina |
| Efficacy and safety of brolucizumab, aflibercept, and ranibizumab for the treatment of patients with visual impairment due to diabetic macular oedema: a systematic review and network meta-analysis. | 2023 | Diabetes Therapy |
| Comparison of antivascular endothelial growth factor treatment for myopia choroidal neovascularisation: a systematic review and meta-analysis of randomised controlled trials. | 2023 | BMJ Open |
| Efficacy of as-needed intravitreal injection compared to 3-monthly loading of anti-vascular endothelial growth factor agents for branch retinal vein occlusion. | 2023 | Scientific Reports |
| Efficacy of ranibizumab combined with photocoagulation for diabetic retinopathy: a meta-analysis study. | 2023 | Medicine |
| Ranibizumab for the treatment of retinopathy of prematurity: systematic review and meta-analysis. | 2023 | Frontiers in Pediatrics |
| Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis. | 2023 | Cochrane Database of Systematic Reviews |
| The management of neovascular age-related macular degeneration: a systematic literature review of patient-reported outcomes, patient mental health and caregiver burden. | 2023 | Acta Ophthalmologica |
| Effect of ranibizumab on retinopathy of prematurity: a meta-analysis. | 2022 | Frontiers in Pharmacology |
| A network meta-analysis of retreatment rates following bevacizumab, ranibizumab, aflibercept, and laser for retinopathy of prematurity. | 2022 | American Academy of Ophthalmology |
| Outcomes of over 40,000 eyes treated for diabetic macula edema in routine clinical practice: a systematic review and meta-analysis. | 2022 | Advanced Therapeutics |
| Long-term outcomes for patients treated for macular oedema secondary to retinal vein occlusion: a systematic review. | 2022 | BMJ Open Ophthalmology |
| Comparative efficacy of brolucizumab in the treatment of neovascular age-related macular degeneration: a systematic literature review and network meta-analysis. | 2022 | Advanced Therapeutics |
| Real-world evidence in the management of diabetic macular edema with intravitreal anti-VEGFs in Asia: a systematic literature review. | 2022 | Clinical Ophthalmology |
| Efficacy and safety of antivascular endothelial growth factor (anti-VEGF) in treating neovascular age-related macular degeneration (AMD): a systematic review and meta-analysis. | 2022 | Journal of Immunology Research |
| Effect of anti-VEGF therapy on the disease progression of neovascular age-related macular degeneration: a systematic review and model-based meta-analysis. | 2022 | Journal of Clinical Pharmacology |
| Comparison of efficacy and safety between conbercept and ranibizumab in neovascular age-related macular degeneration: a meta-analysis of randomized controlled trials. | 2022 | Ophthalmic Research |
| Managing neovascular age-related macular degeneration in clinical practice: systematic review, meta-analysis, and meta-regression. | 2022 | Journal of Clinical Medicine |
| The 12- and 24-month effects of intravitreal ranibizumab, aflibercept, and bevacizumab on intraocular pressure a network meta-analysis. | 2021 | American Academy of Ophthalmology |
| Comparative efficacy and safety of different regimens of ranibizumab for neovascular age-related macular degeneration: a network meta-analysis of randomised controlled trials. | 2021 | BMJ Open |
| Intravitreal ranibizumab versus dexamethasone implant in macular edema due to branch retinal vein occlusion: systematic review and meta-analysis. | 2021 | European Journal of Ophthalmology |
| Disease stability and extended dosing under anti-VEGF treatment of exudative age-related macular degeneration (AMD) - A meta-analysis. | 2021 | Graefe’s Archive for Clinical and Experimental Ophthalmology |
| Anti-vascular endothelial growth factor therapy for age-related macular degeneration: a systematic review and network meta-analysis. | 2021 | Systematic Reviews |
| Ranibizumab and conbercept for treating wet age-related macular degeneration in China: a systematic review and meta-analysis. | 2021 | Medicine Open |
| Efficacy and safety of various treatments for proliferative diabetic retinopathy: a systematic review and network meta-analysis. | 2021 | Frontiers in Pharmacology |
| Managing diabetic macular edema in clinical practice: systematic review and meta-analysis of current strategies and treatment options. | 2021 | Clinical Ophthalmology |
| A systematic review and meta-analysis to compare the efficacy of conbercept with ranibizumab in patients with macular edema secondary to retinal vein occlusion. | 2020 | Medicine |
| Intravitreal ranibizumab versus dexamethasone implant in macular edema due to branch retinal vein occlusion: systematic review and meta-analysis. | 2020 | European Journal of Ophthalmology |
| Comparative safety of bevacizumab, ranibizumab, and aflibercept for treatment of neovascular age-related macular degeneration (AMD): a systematic review and network meta-analysis of direct comparative studies. | 2020 | Journal of Clinical Medicine |
| Efficacy and treatment burden of intravitreal aflibercept versus intravitreal ranibizumab treat-and-extend regimens at 2 years: network meta-analysis incorporating individual patient data meta-regression and matching-adjusted indirect comparison. | 2020 | Advances in Therapy |
| Comparative efficacy and safety of anti-vascular endothelial growth factor regimens for neovascular age-related macular degeneration: systematic review and Bayesian network meta-analysis. | 2020 | Therapeutic Advances in Chronic Disease |
| Intravitreal steroids for macular edema in diabetes. | 2020 | Cochrane Database of Systematic Reviews |
| Managing diabetic macular edema in clinical practice: systematic review and meta-analysis of current strategies and treatment options. | 2020 | Clinical Ophthalmology |
| Treatment regimens for administration of anti-vascular endothelial growth factor agents for neovascular age-related macular degeneration. | 2020 | Cochrane Database of Systematic Reviews |
| Impact of intravitreal ranibizumab therapy on vision outcomes in diabetic macular edema patients: a meta-analysis. | 2020 | Ophthalmologica |
| Comparison of intravitreal bevacizumab and ranibizumab used for myopic choroidal neovascularization: a PRISMA-compliant systematic review and meta-analysis of randomized controlled trials. | 2019 | Medicine |
| Intravitreal corticosteroid implant vs intravitreal ranibizumab for the treatment of macular edema: a meta-analysis of randomized controlled trials. | 2019 | Drug, Design, Development and Therapy |
| Assessment report: Lucentis. | 2019 | European Medicines Agency |
| Effect of intravitreal anti-vascular growth factor agents with or without macular photocoagulation on diabetic macular edema: a systematic review and meta-analysis. | 2019 | Diabetes Therapy |
| Comparison of conbercept and ranibizumab for the treatment efficacy of diabetic macular edema: a meta-analysis and systematic review. | 2019 | International Journal of Ophthalmology |
| Current outcomes of anti-VEGF therapy in the treatment of macular oedema secondary to branch retinal vein occlusions: a meta-analysis. | 2019 | Ophthalmologica |
| A systematic review and meta-analysis of clinical outcomes of intravitreal anti-VEGF agent treatment immediately after cataract surgery for patients with diabetic retinopathy. | 2019 | Journal of Ophthalmology |
| Efficacy of ranibizumab for the treatment of diabetic retinopathy: a protocol for systematic review of randomized controlled trial. | 2019 | Medicine |
